SagilityQ1 FY27
Sagility Q1 FY27 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Price: ₹43P/E: 19.8Market Cap: ₹20.3K CrSector: IT - Services
Management growth scorecard
Revenue
Category 3
Margin
Category 3
Fundraise
N/A
Order
N/A
Capex
Yes
1 of 3 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
Category 3- →The company expects to maintain low double-digit organic growth on a year-on-year basis, guided confidently towards double-digit growth (Page 13).
- →Seasonal revenues, especially from BroadPath related to Medicare sales and enrollment, are expected to continue at similar proportions as FY 2026 (around 6% of revenues) in FY 2027 (Page 19-20).
- →There is broad-based growth across both existing and new clients, with additional services being sold to existing clients, contributing to volume growth (Page 11-12).
- →Incremental growth is also expected from managed service deals and outcome-based contracts, though some deals require longer sales cycles (Page 16).
- →The company has been adding around 15 to 20 clients per quarter, reflecting broad client acquisition contributing to revenue growth (Page 12).
- →Potential for cross-sell opportunities through recent acquisitions, such as CareSeed, enhancing capabilities and client base (Page 5).
Margin guidance
Category 3- →The company expects to deliver low double-digit organic revenue growth in FY 2027, consistent with previous guidance.
- →Adjusted EBITDA margin guidance is maintained at 24% to 25% despite a 120 basis points headwind from minimum wage hikes.
- →Operational efficiencies and favorable currency movements are expected to help absorb wage-related margin pressures.
- →Adjusted PAT margin improved, with underlying profitability showing resilience despite wage cost increases.
- →Seasonal revenue patterns, especially related to U.S. open enrolment, are expected to continue at similar proportions as FY 2026.
- →No pricing increases are anticipated due to client cost pressures; growth driven primarily by volume and new services.
- →The full impact of wage hikes will be clearer by the end of Q2 FY 2027, with updated guidance expected then.
- →Long-term growth is supported by expanding clinical services, managed services deals, and technology/analytics investments.
3 more insights locked — sign up free to unlock
Fundraise plans
- →The company is on track to fully repay its outstanding debt during FY 2027.
- →Debt repayment is progressing, primarily driven by the CareSeed acquisition debt and foreign exchange movements.
- →The balance sheet remains strong, with INR 9,674 million cash and cash equivalents at the end of Q1 FY 2027.
- →The company aims to maintain a prudent capital allocation approach, balancing growth investment and balance sheet flexibility.
- →There is no mention of any new fundraising plans through debt or equity in the current period.
- →Focus is on sustaining healthy cash generation while investing strategically.
- →Overall, the emphasis is on debt repayment rather than raising new external funds.
Order book
The transcript on the provided pages does not explicitly mention details about the current or expected order book or pending orders. However, some related insights include:
- The company continues to have active conversations and engagements for managed service deals, which may take 3-6 months to close, indicating a healthy pipeline.
- Client additions remain strong, with 26-30 new clients added recently, including from acquisitions like CareSeed and BroadPath, showing growing order intake.
- There is confidence in broad-based growth across existing and new clients, supporting expected double-digit organic growth.
- Seasonal revenues linked to Medicare sales (BroadPath) and open enrollment season continue to be significant contributors.
- Management expects visibility on full-year outlook and order trends to improve after Q2, especially post open enrollment season.
No specific quantitative orderbook or pending order values are disclosed in the excerpt.
Capex plans
Yes- →The company continues to invest strategically in technology, analytics, and AI capabilities to support transformative managed service deals and enhance service capabilities across the healthcare value chain.
- →There is ongoing capital allocation balancing growth investment and maintaining balance sheet flexibility.
- →In Q1 FY 2027, fixed asset additions amounted to INR 745 million.
- →The company remains confident in sustaining healthy cash generation to support investments in growth.
- →Post-acquisition integration (e.g., BroadPath, CareSeed) supports expansion in mid- and small-payer markets and new capabilities, indicating possible ongoing investment in these strategic areas.
- →Full repayment of outstanding debt is planned during FY 2027 to strengthen the balance sheet and reduce finance costs, indirectly freeing up capital for future investments.
- →No specific new capex projects or amounts beyond these points are detailed in the provided pages.
How does Sagility rank vs peers in IT - Services?
Pro feature1Sagility
Rev 3Mar 3
See full IT - Services sector rankings
How does Sagility rank in IT - Services?
Compare Sagility against every IT - Services company (Q1 FY27) on revenue, margins and earnings-call signals.